LIVN | LivaNovaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$79.90
-$0.31 (-0.39%)

LivaNova (LIVN) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.

The 50 SMA has sat above the 200 on the daily since Aug 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $79.90 vs 50 $78.56 / 200 $73.07
Projection
No cross projected
Test
No active test
Last cross
Golden cross 13 Aug 2025 ยท projected 5 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $78.97 vs 50 $71.06 / 200 $55.19
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 2 Mar 2026 ยท projected 30 bars out

Cross history

24
crosses on record since 2019
12 golden12 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
5 Oct 2026Death4-hour16 bars outNot tested
11 May 2026Golden4-hour6 bars outNot tested
7 Apr 2026Death4-hour29 bars out5 bar cross test
week of 2 Mar 2026Golden moderateweekly30 bars outNot tested
13 Aug 2025Golden flatdaily5 bars outNot tested

About LIVN

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$45.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.